| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA615436 | F | Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as KI | human rhinovirus type 14 | 5 | organism-based format | Scientific Literature | ||
| 2. | ALA615437 | F | Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as kinact | human rhinovirus type 14 | 5 | organism-based format | Scientific Literature | ||
| 3. | ALA688671 | F | Cytotoxic activity against HRV-14 in cell culture | rhinovirus 14 | 88 | organism-based format | Scientific Literature | ||
| 4. | ALA877209 | F | Antiviral activity against HRV-14 in cell culture | rhinovirus B14 | 89 | organism-based format | Scientific Literature | ||
| 5. | ALA691216 | F | Anti-HRV activity against HRV serotype 14 | human rhinovirus type 14 | 3 | organism-based format | Scientific Literature | ||
| 6. | ALA691397 | F | In vitro antiviral activity against human rhinovirus-14 using plaque reduction assay | human rhinovirus type 14 | 4 | organism-based format | Scientific Literature | ||
| 7. | ALA691044 | F | In vitro determined against HRV-14 in a plaque reduction assay | human rhinovirus type 14 | 5 | organism-based format | Scientific Literature | ||
| 8. | ALA691045 | F | Minimum inhibitory concentration in vitro against HRV-14 in a plaque reduction assay | human rhinovirus type 14 | 18 | organism-based format | Scientific Literature | ||
| 9. | ALA691046 | F | Minimum inhibitory concentration in vitro against HRV-14 in a plaque reduction assay; NA=Not active | human rhinovirus type 14 | 4 | organism-based format | Scientific Literature | ||
| 10. | ALA691047 | F | In vitro antiviral activity against human rhinovirus-14 using plaque reduction assay | human rhinovirus type 14 | 28 | organism-based format | Scientific Literature | ||
| 11. | ALA690846 | F | In vitro antiviral activity against human rhinovirus-14 using plaque reduction assay; not active | human rhinovirus type 14 | 5 | organism-based format | Scientific Literature | ||
| 12. | ALA690847 | F | % survivors was determined against mutants of human rhinovirus 14 by extended cycle replication assay in 1 ug/mL enviroxime | rhinovirus 14 | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA687704 | F | % survivors was determined against mutants of human rhinovirus 14 by extended cycle replication assay in 1 ug/mL enviroxime by different amino acid substitution | rhinovirus 14 | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA687705 | F | % survivors was determined against mutants of human rhinovirus 14 by extended cycle replication assay in 1 ug/mL enviroxime by different amino acid substitution by different amino acid substitution | rhinovirus 14 | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA687706 | F | Anti-HRV activity against HRV-14 strain | human rhinovirus type 14 | 12 | organism-based format | Scientific Literature | ||
| 16. | ALA697142 | F | Antiviral activity against human rhinovirus-14 (HRV-14) in HeLa-cells using cell assay | human rhinovirus type 14 | 16 | organism-based format | Scientific Literature | ||
| 17. | ALA698994 | F | Antiviral activity against human rhinovirus 14 using plaque reduction assay in HeLa cell lines | human rhinovirus type 14 | 18 | organism-based format | Scientific Literature | ||
| 18. | ALA874128 | F | Compound was evaluated for inhibitory effect against human Rhinovirus-14 | human rhinovirus-14 | 9 | organism-based format | Scientific Literature | ||
| 19. | ALA698711 | F | In vitro antiviral activity against human rhinovirus 1B serotype | human rhinovirus type 14 | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA696496 | F | Inhibitory activity against human rhinovirus-14 in cell culture | human rhinovirus type 14 | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!